VertiFlex Announces Publication of Superion® IDE Trial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of advanced minimally invasive interventions for spinal stenosis, announces publication of two-year clinical results of the Superion® Indirect Decompression System. Dr. Vikas Patel, from the University of Colorado, and colleagues, reported outcomes from the first 250 patients enrolled in a prospective, multi-center, randomized FDA IDE trial comparing results of the minimally invasive Superion Indirect Decompression System to an alternative surgical control device. This peer-reviewed research paper is published in BMC Musculoskeletal Disorders and can be found at the flowing link http://www.biomedcentral.com/1471-2474/15/221/abstract.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC